A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease

• Main Authors: Joji Tokita (Author), David Lam (Author), Aida Vega (Author), Stephanie Wang (Author), Leonard Amoruso (Author), Tamara Muller (Author), Nidhi Naik (Author), Shivani Rathi (Author), Sharlene Martin (Author), Azadeh Zabetian (Author), Catherine Liu (Author), Catherine Sinfield (Author), Tony McNicholas (Author), Fergus Fleming (Author), Steven G. Coca (Author), Girish N Nadkarni (Author), Roger Tun (Author), Mike Kattan (Author), Michael J. Donovan (Author), Arshad K. Rahim (Author)
• Format: Book
• Published: SAGE Publishing, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction/Objective: The KidneyIntelX is a multiplex, bioprognostic, immunoassay consisting of 3 plasma biomarkers and clinical variables that uses machine learning to predict a patient's risk for a progressive decline in kidney function over 5 years. We report the 1-year pre- and post-test...